Smoking is the leading cause of preventable morbidity, mortality, and health inequalities in New Zealand, and is estimated to cause 4,500 to 5,000 deaths every year.
Tobacco is a uniquely harmful consumer product responsible for the premature death of half its long-term users. No other legal consumer product causes such widespread harm; smoking harms nearly every organ of the body and is a leading cause of cancer, heart disease, respiratory disease, and a range of other conditions.
The New Zealand Government has commitment to making Aotearoa New Zealand smokefree by the year 2025, which means a reduction in smoking prevalence to less than 5% and a reduction in availability of tobacco to minimal levels. Research has an important role to play in achieving this national goal.
While maintaining a broad interest in all aspects of tobacco control, our research team focuses on reducing the availability of tobacco. Our research includes spatial analyses of the locations of tobacco retailers, and examining policy options for reducing availability. We also undertake research in the area of e-cigarettes and vaping, such as assessing the retail availability and marketing of e-cigarettes and vaping products, and identifying measures to support smokers to transition to exclusive vaping.
Current smokefree projects
- Geospatial mapping of different tobacco retail reduction policies
- Systematic review on retail access to tobacco and smoking
- Exploring tobacco retailers’ knowledge of and experiences with selling e-cigarettes ad vaping products, and their attitudes towards policy options for tobacco and e-cigarettes
- Electronic cigarettes and vaping: Retailing, point of sale marketing, and users’ experiences
Smokefree research team
- Dr Louise Marsh Senior Research Fellow
- Dr Lindsay Robertson Research Fellow
- Professor Rob McGee Professor